Terms: = Kidney tumors AND ATIC, IMPCHASE, 471, ENSG00000138363, AICARFT, P31939, PURH AND Treatment
20 results:
1. Cytoreductive Nephrectomy for Patients with Metastatic Sarcomatoid and/or Rhabdoid Renal Cell Carcinoma Treated with Immune Checkpoint Therapy.
Hahn AW; Kotecha RR; Viscuse PV; Pieretti AC; Wiele AJ; Jonasch E; Lee CH; Gao J; Zurita AJ; Shah AY; Campbell MT; Sharma P; Motzer RJ; Russo P; Wood CG; Tannir NM; Voss MH; Karam JA; Hakimi AA; Msaouel P
Eur Urol Focus; 2023 Sep; 9(5):734-741. PubMed ID: 36863962
[TBL] [Abstract] [Full Text] [Related]
2. A Matching-adjusted Indirect Comparison of Nivolumab Plus Cabozantinib Versus Pembrolizumab Plus Axitinib in Patients with Advanced Renal Cell Carcinoma.
McGregor B; Geynisman DM; Burotto M; Suárez C; Bourlon MT; Barata PC; Gulati S; Huo S; Ejzykowicz F; Blum SI; Del Tejo V; Hamilton M; May JR; Du EX; Wu A; Kral P; Ivanescu C; Chin A; Betts KA; Lee CH; Choueiri TK; Cella D; Porta C
Eur Urol Oncol; 2023 Jun; 6(3):339-348. PubMed ID: 36842942
[TBL] [Abstract] [Full Text] [Related]
3. Disparities in Survival and Comorbidity Burden Between Asian and Native Hawaiian and Other Pacific Islander Patients With Cancer.
Taparra K; Qu V; Pollom E
JAMA Netw Open; 2022 Aug; 5(8):e2226327. PubMed ID: 35960520
[TBL] [Abstract] [Full Text] [Related]
4. Adverse Urinary System Outcomes among Older Women with Endometrial Cancer.
Anderson C; Lund JL; Park J; Brewster W; Bae-Jump V; Olshan AF; Nichols HB
Cancer Epidemiol Biomarkers Prev; 2022 Jul; 31(7):1508. PubMed ID: 35775217
[TBL] [Abstract] [Full Text] [Related]
5. Survival nomogram for patients with bone metastatic renal cell carcinoma: A population-based study.
Wang K; Wu Z; Wang G; Shi H; Xie J; Yin L; Xu T; Mao W; Peng B
Int Braz J Urol; 2021; 47(2):333-349. PubMed ID: 33284535
[TBL] [Abstract] [Full Text] [Related]
6. Integrated proteomics and metabolomics reveals the comprehensive characterization of antitumor mechanism underlying Shikonin on colon cancer patient-derived xenograft model.
Chen Y; Ni J; Gao Y; Zhang J; Liu X; Chen Y; Chen Z; Wu Y
Sci Rep; 2020 Aug; 10(1):14092. PubMed ID: 32839531
[TBL] [Abstract] [Full Text] [Related]
7. CT and MR imaging surveillance of stage 1 renal cell carcinoma after microwave ablation.
Wetley KA; Abel EJ; Dreyfuss LD; Huang W; Brace CL; Wells SA
Abdom Radiol (NY); 2020 Sep; 45(9):2810-2824. PubMed ID: 32715335
[TBL] [Abstract] [Full Text] [Related]
8. The renal cell cancer database Sweden (RCCBaSe) - a new register-based resource for renal cell carcinoma research.
Landberg A; Lindblad P; Harmenberg U; Lundstam S; Ljungberg B; Thorstenson A; Sundqvist P
Scand J Urol; 2020 Jun; 54(3):235-240. PubMed ID: 32436435
[No Abstract] [Full Text] [Related]
9. Genomically annotated risk model for advanced renal-cell carcinoma: a retrospective cohort study.
Voss MH; Reising A; Cheng Y; Patel P; Marker M; Kuo F; Chan TA; Choueiri TK; Hsieh JJ; Hakimi AA; Motzer RJ
Lancet Oncol; 2018 Dec; 19(12):1688-1698. PubMed ID: 30416077
[TBL] [Abstract] [Full Text] [Related]
10. Prevalence of Renal Angiomyolipomas and Spontaneous Bleeding Related to Angiomyolipomas in Tuberous Sclerosis Complex Patients in France and Norway-a Questionnaire Study.
Cockerell I; Guenin M; Heimdal K; Bjørnvold M; Selmer KK; Rouvière O
Urology; 2017 Jun; 104():70-76. PubMed ID: 28232177
[TBL] [Abstract] [Full Text] [Related]
11. Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell Carcinoma.
Hsieh JJ; Chen D; Wang PI; Marker M; Redzematovic A; Chen YB; Selcuklu SD; Weinhold N; Bouvier N; Huberman KH; Bhanot U; Chevinsky MS; Patel P; Pinciroli P; Won HH; You D; Viale A; Lee W; Hakimi AA; Berger MF; Socci ND; Cheng EH; Knox J; Voss MH; Voi M; Motzer RJ
Eur Urol; 2017 Mar; 71(3):405-414. PubMed ID: 27751729
[TBL] [Abstract] [Full Text] [Related]
12. treatment for T1a Renal Cancer Substratified by Size: "Less is More".
Moskowitz D; Chang J; Ziogas A; Anton-Culver H; Clayman RV
J Urol; 2016 Oct; 196(4):1000-7. PubMed ID: 27113965
[TBL] [Abstract] [Full Text] [Related]
13. Circulating biomarkers and outcome from a randomised phase II trial of sunitinib vs everolimus for patients with metastatic renal cell carcinoma.
Voss MH; Chen D; Marker M; Hakimi AA; Lee CH; Hsieh JJ; Knox JJ; Voi M; Motzer RJ
Br J Cancer; 2016 Mar; 114(6):642-9. PubMed ID: 26908330
[TBL] [Abstract] [Full Text] [Related]
14. Prostatectomy for localized prostate cancer to prepare for renal transplantation in end-stage renal disease patients.
Tillou X; Chahwan C; Le Gal S; Bensadoun H; Doerfler A
Ann Transplant; 2014 Nov; 19():569-75. PubMed ID: 25374252
[TBL] [Abstract] [Full Text] [Related]
15. Phase II randomized trial comparing sequential first-line everolimus and second-line sunitinib versus first-line sunitinib and second-line everolimus in patients with metastatic renal cell carcinoma.
Motzer RJ; Barrios CH; Kim TM; Falcon S; Cosgriff T; Harker WG; Srimuninnimit V; Pittman K; Sabbatini R; Rha SY; Flaig TW; Page R; Bavbek S; Beck JT; Patel P; Cheung FY; Yadav S; Schiff EM; Wang X; Niolat J; Sellami D; Anak O; Knox JJ
J Clin Oncol; 2014 Sep; 32(25):2765-72. PubMed ID: 25049330
[TBL] [Abstract] [Full Text] [Related]
16. Association between prostate cancer and urinary calculi: a population-based study.
Chung SD; Liu SP; Lin HC
PLoS One; 2013; 8(2):e57743. PubMed ID: 23451265
[TBL] [Abstract] [Full Text] [Related]
17. Volume-outcome relationships in the treatment of renal tumors.
Abouassaly R; Finelli A; Tomlinson GA; Urbach DR; Alibhai SM
J Urol; 2012 Jun; 187(6):1984-8. PubMed ID: 22498222
[TBL] [Abstract] [Full Text] [Related]
18. [Long-term investigation of the risk of malignant diseases following intravenous radium-224 treatment for ankylosing spondylitis].
Schulte TL; Nekolla EA; Wick RR
Strahlenther Onkol; 2009 Sep; 185(9):549-56. PubMed ID: 19756420
[TBL] [Abstract] [Full Text] [Related]
19. Excise, ablate or observe: the small renal mass dilemma--a meta-analysis and review.
Kunkle DA; Egleston BL; Uzzo RG
J Urol; 2008 Apr; 179(4):1227-33; discussion 1233-4. PubMed ID: 18280512
[TBL] [Abstract] [Full Text] [Related]
20. [treatment of renal cell carcinoma with human lymphoblastoid interferon alpha and UFT in combination. A prospective multicenter trial].
Akaza H; Kameyama S; Kanemura M; Kitajima K; Homma Y; Kawamura T; Okada K; Murahashi I; Kawabe K; Isurugi K
Nihon Hinyokika Gakkai Zasshi; 1991 Jul; 82(7):1053-8. PubMed ID: 1895617
[TBL] [Abstract] [Full Text] [Related]